Cargando…

Local immunomodulation with Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance

Islet transplantation is a promising therapy for type 1 diabetes. However, chronic immunosuppression to control rejection of allogeneic islets induces morbidities and impairs islet function. T-effector cells are responsible for islet allograft rejection and express Fas death receptor following activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Headen, Devon M., Woodward, Kyle B., Coronel, María M., Shrestha, Pradeep, Weaver, Jessica D., Zhao, Hong, Tan, Min, Hunckler, Michael D., Bowen, William S., Johnson, Christopher T., Shea, Lonnie, Yolcu, Esma S., García, Andrés J., Shirwan, Haval
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060019/ https://www.ncbi.nlm.nih.gov/pubmed/29867165 http://dx.doi.org/10.1038/s41563-018-0099-0

Ejemplares similares

Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes
por: Yolcu, Esma S., et al.
Publicado: (2017)

Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites
por: Weaver, Jessica D., et al.
Publicado: (2017)

Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival
por: Coronel, María M., et al.
Publicado: (2020)

FasL microgels induce immune acceptance of islet allografts in nonhuman primates
por: Lei, Ji, et al.
Publicado: (2022)

A modified surgical procedure using minimally invasive ileocolic vein perfusion in a mouse intrahepatic islet transplant model
por: Zhang, Lei, et al.
Publicado: (2022)

Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease
por: Shrestha, Pradeep, et al.
Publicado: (2023)

Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective
por: Yolcu, Esma S., et al.
Publicado: (2017)

4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4(+)CD25(+)FoxP3(+) T Regulatory Cell Suppression
por: Barsoumian, Hampartsoum B., et al.
Publicado: (2016)

Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy
por: Sharma, Rajesh Kumar, et al.
Publicado: (2010)

CD4(+) T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models
por: Sharma, Rajesh K., et al.
Publicado: (2013)

Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines
por: Shirwan, Haval, et al.
Publicado: (2013)

Effector and Naturally Occurring Regulatory T Cells Display No Abnormalities in Activation Induced Cell Death in NOD Mice
por: Kaminitz, Ayelet, et al.
Publicado: (2011)

SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
por: Madireddi, Shravan, et al.
Publicado: (2012)

Correction: SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
por: Madireddi, Shravan, et al.
Publicado: (2012)

Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8(+) T and NK Cell Dependent Manner
por: Srivastava, Abhishek K., et al.
Publicado: (2012)

Bioengineered omental transplant site promotes pancreatic islet allografts survival in non-human primates
por: Deng, Hongping, et al.
Publicado: (2023)

The inflammasome in biomaterial‐driven immunomodulation
por: Vasconcelos, Daniela P., et al.
Publicado: (2022)

Navigating ethical challenges in the development and translation of biomaterials research
por: Hunckler, Michael D., et al.
Publicado: (2022)

Immunomodulation Effect of Biomaterials on Bone Formation
por: Zhao, Tong, et al.
Publicado: (2022)

The Use of Biomaterials in Islet Transplantation
por: Borg, Danielle J., et al.
Publicado: (2011)

The role of dendritic cells in the immunomodulation to implanted biomaterials
por: Wang, Siyuan, et al.
Publicado: (2022)

Hydrogen sulfide promotes immunomodulation of gingiva-derived mesenchymal stem cells via the Fas/FasL coupling pathway
por: Yang, Ruili, et al.
Publicado: (2018)

Editorial: Adverse Reactions to Biomaterials: State of the Art in Biomaterial Risk Assessment, Immunomodulation and in vitro Models for Biomaterial Testing
por: Vrana, Nihal Engin, et al.
Publicado: (2019)

KRP-203 Is a Desirable Immunomodulator for Islet Allotransplantation
por: Fathi, Ibrahim, et al.
Publicado: (2021)

Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants
por: Li, Ying, et al.
Publicado: (2021)

Immunomodulation and Biomaterials: Key Players to Repair Volumetric Muscle Loss
por: Kiran, Sonia, et al.
Publicado: (2021)

The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation
por: Sousa, Ana Beatriz, et al.
Publicado: (2023)

A DNA Vaccine Encoding SA-4-1BBL Fused to HPV-16 E7 Antigen Has Prophylactic and Therapeutic Efficacy in a Cervical Cancer Mouse Model
por: Garza-Morales, Rodolfo, et al.
Publicado: (2019)

The Current Status of Allogenic Islet Cell Transplantation
por: Czarnecka, Zofia, et al.
Publicado: (2023)

Graphene-Oxide-Enriched Biomaterials: A Focus on Osteo and Chondroinductive Properties and Immunomodulation
por: Ricci, Alessia, et al.
Publicado: (2022)

The function of immunomodulation and biomaterials for scaffold in the process of bone defect repair: A review
por: Dong, Changchao, et al.
Publicado: (2023)

Engineering of hybrid spheroids of mesenchymal stem cells and drug depots for immunomodulating effect in islet xenotransplantation
por: Nguyen, Tiep Tien, et al.
Publicado: (2022)

In Vitro and In Vivo Improvement of Islet Quality and Transplantation Successes following Islet Treatment with Biomaterials in Diabetic Rats
por: Nemati, Marzieh, et al.
Publicado: (2023)

Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells
por: Lebreton, Fanny, et al.
Publicado: (2021)

Clinical Allogeneic and Autologous Islet Cell Transplantation: Update
por: Matsumoto, Shinichi
Publicado: (2011)

Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
por: Nayak, Deepak Kumar, et al.
Publicado: (2016)

Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis
por: Lasola, Jackline Joy Martín, et al.
Publicado: (2020)

Interactions Between Immunomodulatory Biomaterials and Immune Microenvironment: Cues for Immunomodulation Strategies in Tissue Repair
por: Chen, Yi, et al.
Publicado: (2022)

Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
por: Borovjagin, Anton V., et al.
Publicado: (2014)

Precision health for breast cancer metastasis: biomaterial scaffolds as an engineered metastatic niche to define, study, and monitor metastatic progression
por: Bushnell, Grace G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r7e72okkli7o6q7igss91ako15